About
Resilientbiotics develops microbiome-derived, live biotherapeutics aimed at preventing respiratory infectious diseases in both animal and human health sectors by leveraging microbiome genomics and data science.
Explore Resilientbiotics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.